Green-lipped mussel (Perna canaliculus) extract efficacy in knee osteoarthritis and improvement in gastrointestinal dysfunction: A pilot study

Inflammopharmacology

Volumn 20, Issue 2, 2012, Pages 71-76

  Coulson, Samantha ^a   Vecchio, Phillip ^b   Gramotnev, Helen ^a   Vitetta, Luis ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Gastrointestinal function; Green lipped muscle extract; Osteoarthritis

Indexed keywords

GLYCOMEGA PLUS; GREEN LIPPED MUSSEL EXTRACT; NATURAL PRODUCT; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; GASTROINTESTINAL REFLUX; GOUT; HUMAN; JOINT MOBILITY; JOINT STIFFNESS; KNEE OSTEOARTHRITIS; KNEE PAIN; MALE; MUSSEL; PERNA CANALICULUS; PILOT STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PERNA; PILOT PROJECTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; TISSUE EXTRACTS; TREATMENT OUTCOME;

EID: 84863101970     PISSN: 09254692     EISSN: 15685608     Source Type: Journal    
DOI: 10.1007/s10787-012-0128-6     Document Type: Article

References (28)

1. Altman R, Asch E, Bloch D et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29(8):1039-1049.
2. Armstrong AR, Thiébaut SP, Brown LJ (2011) Australian adults use complementary and alternative medicine in the treatment of chronic illness: a national study. Aust NZ J Public Health 35:384-390.
3. Bellamy N (2002) WOMAC: a 20-year experiential review of a patient-centered self-reported health status questionnaire. J Rheumatol 29(12):2473-2476.
4. Brien S, Prescott P, Coghlan B et al (2008) Systematic review of the nutritional supplement Perna canaliculus (green-lipped mussel) in the treatment of osteoarthritis. QJM 101:167-179.
5. Buchanan WW, Kean WF (2002a) Osteoarthritis: II: pathology and pathogenesis. Inflammopharmacol 10:19-48.
6. Buchanan WW, Kean WF (2002b) Osteoarthritis: III: radiological and clinical definition. Inflammopharmacol 10:53-78.
7. Buchanan WW, Kean WF (2002c) Osteoarthritis IV: clinical therapeutic trials and treatment. Inflammopharmacol 10:75-149.
8. Chang J, Locke GR, Schleck CD et al (2007) Risk factors for chronic constipation and a possible role of analgesics. Neurogastroenterol Motil 19:905-911.
9. Chong VH, Wang CL (2008) Higher prevalence of gastrointestinal symptoms among patients with rheumatic disorders. Singapore Med J 49:419-424.
10. Etienney I, Beaugerie L, Viboud C et al (2003) Non-steroidal antiinflammatory drugs as a risk factor for acute diarrhoea: a case crossover study. Gut 52:260-263.
11. Garcia-Rodriguez LA, Cattaruzzi C et al (1998) Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med 158:33-39.
12. Lequesne MG, Maheu E (2003) Clinical and radiological evaluation of hip, knee and hand osteoarthritis. Aging Clin Exp Res 15(5):380-390.
13. Lequesne MG, Mery C, Samson M et al (1987) Indexes of severity for osteoarthritis of the hip and knee. Validation value in comparison with other assessment tests. Scand J Rheumatol Suppl 65:85-89.
14. Locke GR, Zinsmeister AR, Talley NJ et al (2000) Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol 95:905-911.
15. Peuhkuri K, Vapaatalo H, Korpela R (2010) Even low-grade inflammation impacts on small intestinal function. World J Gastroenterol 16:1057-1062.
16. Possemiers S, Bolca S, Verstraete W et al (2011) The intestinal microbiome: a separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals. Fitoterapia 82:53-66.
17. Rahme E, Pettitt D, LeLorier J (2002) Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population. Arthritis Rheum 46:3046-3054.
18. Rainsford KD, Whitehouse MW (1980) Gastroprotective and antiinflammatory properties of green lipped mussel (Perna canaliculus) preparation. Arzneimittelforschung 30:2128-2132.
19. Roderiguez GL, Hernandez-Diaz S (2001) Risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology 12:570-576.
20. Scarpignato C, Hunt RH (2010) Nonsteroidal antiinflammatory drugrelated injury to the gastrointestinal tract: clinical picture, pathogenesis and prevention. Gastroenterol Clin N Am 39:433-464.
21. Svedlund J, Sjodin I, Dotevall G (1988) GSRS: a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33:129-134.
22. Tucker G, Adams R, Wilson D (2010) New Australian population scoring coefficients for the old version of the SF-36 and SF-12 health status questionnaires. Qual Life Res 19:1069-1076.
23. Wandel S, Juni P, Tendal B et al (2010) Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 341:c4675.
24. Ware JE, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34(3):220-233.
25. Whitehouse MW, Macrides TA, Kalafatis N et al (1997) Antiinflammatory activity of a lipid fraction (lyprinol) from the NZ green-lipped mussel. Inflammopharmacology 5:237-246.
26. Wieland HA, Michaelis M, Kirschbaum BJ et al (2005) Osteoarthritis- an untreatable disease? Nat Rev Drug Discov 4:331-344.
27. Wolfe MM, Lichtenstein DR, Singh G (1999) Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 340:1888-1899.
28. Zhang W, Moskowitz RW, Nuki G et al (2008) The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis 67:1716-1723.